Adaptis Pharma News & Insights | Pharmacovigilance & Regulatory

News and Blogs

Pharmacovigilance

Maximizing Regulatory Affairs/Pharmacovigilance Efficiency Through Outsourcing: A Competitive Edge for Small and Mid-Sized Pharma Companies

In todayโ€™s ever-evolving and highly regulated pharmaceutical landscape, managing regulatory affairs (RA) and pharmacovigilance (PV) has become a critical and resource-intensive responsibility.

Pharmacovigilance

Patient Safety and the Importance of Pharmacovigilance

Patient safety is a crucial part of healthcare that seeks to protect patients from harm during their treatment and care.

Pharmacovigilance

Understanding 21 CFR 314.80: Post marketing Reporting of Adverse Drug Experiences

21 CFR 314.80 is a regulation established by the U.S. Food and Drug Administration (FDA) to govern the post marketing reporting of adverse drug experiences.

Pharmacovigilance

Strategic Collaboration for Advancing Pharmaceutical Excellence!

Adaptis is delighted to announce the signing of a Memorandum of Understanding (MoU) with Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Pune. This partnership aims to bridge the gap between academia and industry, fostering collaboration and expertise in the pharmaceutical sector.

Pharmacovigilance

A New Chapter of Growth and Unity!

With immense gratitude and joy, we celebrated the inauguration of our new officeโ€”a milestone made possible by unwavering support and blessings. The pooja and lamp-lighting ceremony symbolized the start of a journey filled with hope, unity, and ambition.

Pharmacovigilance

Proud Moment for Pharmacovigilance (PV) Team at Adaptis!

We are thrilled to have played a pivotal role in helping our client successfully clear their USFDA audit. Through our PV expertise in designing and implementing comprehensive Pharmacovigilance systems, strengthening SOP frameworks, and ensuring rigorous PV compliance...

Pharmacovigilance

Celebrating 5 Glorious Years of Adaptis!

๐‘จ ๐’”๐’˜๐’†๐’†๐’• ๐’Ž๐’Š๐’๐’†๐’”๐’•๐’๐’๐’† ๐’„๐’‚๐’๐’๐’” ๐’‡๐’๐’“ ๐’‚ ๐’”๐’˜๐’†๐’†๐’• ๐’„๐’†๐’๐’†๐’ƒ๐’“๐’‚๐’•๐’Š๐’๐’! From our humble beginnings to 5 years of ๐ซ๐ž๐ฌ๐ข๐ฅ๐ข๐ž๐ง๐œ๐ž, ๐ข๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง, ๐š๐ง๐ ๐ฉ๐ฎ๐ซ๐ฉ๐จ๐ฌ๐ž-๐๐ซ๐ข๐ฏ๐ž๐ง ๐ ๐ซ๐จ๐ฐ๐ญ๐ก, this journey has been truly special. A heartfelt thank you to our ๐ข๐ง๐œ๐ซ๐ž๐๐ข๐›๐ฅ๐ž ๐ญ๐ž๐š๐ฆ, ๐ฏ๐ข๐ฌ๐ข๐จ๐ง๐š๐ซ๐ฒ ๐ฅ๐ž๐š๐๐ž๐ซ๐ฌ, ๐ญ๐ซ๐ฎ๐ฌ๐ญ๐ž๐ ๐œ๐ฅ๐ข๐ž๐ง๐ญ๐ฌ, ๐š๐ง๐ ๐ฏ๐š๐ฅ๐ฎ๐ž๐ ๐ฉ๐š๐ซ๐ญ๐ง๐ž๐ซ๐ฌ who made this day possible...

Pharmacovigilance

Adaptis at Iphex 2025 โ€“ New Delhi

During Iphex 2025, our team engaged in insightful discussions and strategic networking with international partners. We highlighted Adaptisโ€™ expertise in Pharmacovigilance and Regulatory Affairs, demonstrating how we empower organizations to achieve regulatory compliance, foster innovation, and drive sustainable growth across global markets.

Chat with us Chat with us!
Pharmacovigilance

How Can We Assist You?